Arbios Systems’ SEPET Going to the Highest Bidder

In August, Arbios Systems suspended operations and laid-off employees as it tried – unsuccessfully – to raise capital. The company has now filed for bankruptcy protection. Given the economy and Arbios’ dire cash position, the company’s board concluded that a Chapter 11 filing was the best course of...

First CTO Crossing with Stereotaxis’ RF PowerAssert Magnetic Guidewire

The first crossing of a chronic total occlusion (CTO) using Stereotaxis’ RF PowerAssert Magnetic Guidewire occurred this week. PowerAssert, FDA cleared in 2008, is the only magnetically controlled device available for crossing peripheral occlusions, including CTOs. Conventional catheters are operated from...

OneMedForum Now Streaming Live!

I encourage everyone to check out the live broadcast of the OneMedForum, taking place today and tomorrow, 8AM – 5PM PST! The OneMedForum highlights the most promising and least known medical technology and device firms. A full schedule of presenting companies can be found...

Insight Dx Prostate Profile: Clarient Launches Gene Expression Test for Prostate Cancer

Clarient has launched a new gene expression diagnostic for prostate cancer, the Insight Dx Prostate Profile (Insight). The test, developed in conjunction with Health Discovery Corp., uses expression values from four genes to identify the presence of prostate cancer cells. In its clinical validation study,...

World Heart Submits IDE Application for Levacor VAD

World Heart Corporation has submitted an FDA Investigational Device Exemption application for a pivotal bridge-to-transplant study of its Levacor Ventricular Assist Device (VAD). Ventricular assist devices are mechanical pumps that enable the restoration of normal blood circulation in patients suffering from...

[Quick Take] Interview with Tom Bjerg Lauritzen, President & CEO of Vivostat

The Vivostat System is an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin (PRF). It incorporates a unique biochemical process that produces an autologous sealant from 120 ml of the patient’s own blood in 23 minutes. The sealant has...

Endurance Rhythm Harnesses the Heart’s Kinetic Energy

Competition among makers of electronic medical implants is intense, and the pressure to differentiate products has led to decreased size and new power-hungry features. As a result, most of the 550,000 pacemakers and Implantable Cardiac Defibrillators (ICDs) placed each year inevitably fail due to limited...

AngioDynamics: No Growth Expected in 2009

It’s been a roller coaster of a year for AngioDynamics. In the past, I’ve professed my high opinion of the company. I still like ANGO and I think it’s fairly valued, but a less than stellar quarter should give growth-obsessed investors pause. The company expects revenues to shrink by $5 million in...